Liesbet M. Peeters

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Steve Simpson, Edward De Brouwer, Tomáš Kalinčík et al. · Cronfa (Swansea University) · 2021 · 157 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis

Tessa Dhaeze, Evelyn Peelen, Anneleen Hombrouck et al. · The Journal of Immunology · 2015 · 137 citations

Life Sciences, Immunology, Pathology +17

Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression

Liesbet M. Peeters, Marjan Vanheusden, Veerle Somers et al. · Frontiers in Immunology · 2017 · 90 citations · Full text

Life Sciences, Immunology, Neurology +17

Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis

J. Yperman, Thijs Becker, Dirk Valkenborg et al. · BMC Neurology · 2020 · 73 citations · Full text

Computing, Computer Science, Neurology +17

COVID-19 in people with multiple sclerosis: A global data sharing initiative

Liesbet M. Peeters, Tina Parciak, Clare Walton et al. · Multiple Sclerosis Journal · 2020 · 63 citations · Full text

Computing, Biomedical Informatics, Health Informatics +14